Innate Pharma
Biotechnology
Healthcare
IPHA
81.05 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
1.86
52 week high
3.02
high
1.90
52 week low
0.00
previous Close
1.83
P/E ratio
market cap
170 M
div yield
0
net incoming
-9.29 M
0.00 %
net profit margin
-43.31 %
0.00 %
operating incoming
-12.27 M
0.00 %
net change in cash
-809.00 K
0.00 %
cash on hand
70.61 M
0.00 %
cost of revenue
24.57 M
0.00 %
top